Sandbox encephalitis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "==Encephalitis== {| | valign=top | <div style="height: 30px; line-height: 30px; width: 225px; background: #A5B2D6; border: 2px solid #696969; border-bottom: 0px; text-align: ...")
 
No edit summary
Line 49: Line 49:
|}
|}
|}
|}
{| class="wikitable mw-collapsible mw-collapsed" id="mw-customcollapsible-table02" style="border: 2px solid #696969;"
{| class="wikitable mw-collapsible mw-collapsed" id="mw-customcollapsible-table03" style="border: 2px solid #696969;"
|-
|-
| valign=top |
| valign=top |
Line 63: Line 63:
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Foscarnet]] 60 mg/kg IV q8h or 90 mg/kg IV q12h'''''
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Foscarnet]] 60 mg/kg IV q8h or 90 mg/kg IV q12h'''''
|-
|-
|}
|}
{| class="wikitable mw-collapsible mw-collapsed" id="mw-customcollapsible-table05" style="border: 2px solid #696969;"
|-
| valign=top |
{| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 400px;"
! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | {{fontcolor|#1F4099|Human herpesvirus 6}}
|-
! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Immunocompromised Patients''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ganciclovir]] 5 mg/kg IV q12 h'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | OR
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Foscarnet]] 60 mg/kg IV q8h or 90 mg/kg IV q12h'''''
|-
! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Immunocompetent Patients''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''No good data on effectiveness yet'''''
|-
|}
|}
{| class="wikitable mw-collapsible mw-collapsed" id="mw-customcollapsible-table06" style="border: 2px solid #696969;"
|-
| valign=top |
{| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 400px;"
! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | {{fontcolor|#1F4099|B virus}}
|-
! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Preferred Regimen''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Valacyclovir]] 5 mg/kg IV q12 h'''''
|-
! style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | ''Alternative Regimen''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ganciclovir]]'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | AND
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Acyclovir]]'''''
|-
|}
|}
|}
|}

Revision as of 17:12, 24 January 2014

Encephalitis

Community-Acquired
  ▸  Herpes simplex virus
  ▸  Varicella zoster virus
  ▸  Cytomegalovirus
  ▸  Epstein-Barr virus
  ▸  Human herpesvirus 6
  ▸  B Virus
  ▸  Other viruses
  ▸  ADEM
Herpes simplex virus
patients with normal renal function
▸ Acyclovir 10 mg/kg IV q8h(for 14-21 days)
neonates
▸ Acyclovir 20 mg/kg IV q8h(for 21 days)
Varicella zoster virus
Preferred Regimen
▸ acyclovir 10–15 mg/kg IV q8h (for 10–14 days)
PLUS
▸ Cefotaxime 50 mg/kg IV q6—8h
Alternative Regimen
▸ Ganciclovir
Cytomegalovirus
Preferred Regimen
▸ Ganciclovir 5 mg/kg IV q12 h
PLUS
▸ Foscarnet 60 mg/kg IV q8h or 90 mg/kg IV q12h
Human herpesvirus 6
Immunocompromised Patients
▸ Ganciclovir 5 mg/kg IV q12 h
OR
▸ Foscarnet 60 mg/kg IV q8h or 90 mg/kg IV q12h
Immunocompetent Patients
▸ No good data on effectiveness yet
B virus
Preferred Regimen
▸ Valacyclovir 5 mg/kg IV q12 h
Alternative Regimen
▸ Ganciclovir
AND
▸ Acyclovir
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox_encephalitis&oldid=934463"